Georgia Veterans Disability Benefit Attorneys

For denied VA claims, you must file an appeal with the VA letting them know that you dispute the decision they reached on all or part of your claim. Under the Appeal Modernization Act, you have three different appeals lanes from which to choose. Which one is best depends on the facts and circumstances of your particular situation. Regardless of which appeal option you choose, you have up to a year from the date of the VA’s decision, but it is recommended that you file this as soon as possible to eliminate any unnecessary delay in the appeal of your claim. Once you receive a decision from VA, Perkins Studdard LLC in Carrollton and LaGrange may be able to represent you in correcting the errors made in the initial decision so you get the VA benefits you deserve.

Yes. Total Disability Based on Individual Unemployability (TDIU) is a benefit under the VA’s disability compensation program that pays qualifying veterans at the 100% rate even though the VA has not rated their service-connected disabilities at the 100% level. Generally, the veteran must have at least one service-connected disability rated at 60% or more OR in the case of multiple disabilities have one rated at least 40% with a combined rating of 70% or more. The service-connected disabilities must be sufficient to prevent the veteran from performing the mental or physical tasks required to obtain or keep employment.

If your condition is included on the list of diseases caused by Agent Orange
or among the types of cancer caused by Agent Orange exposure, you may be eligible to receive monthly disability compensation.

Or, if you are the dependent of a veteran who dies as the result of one of these diseases, you may be entitled to Dependency and Indemnity Compensation (DIC). The following is the current list of diseases presumed to be caused by Agent Orange exposure (38 C.F.R. § 3.309(e)): 

• AL amyloidosis
• Chloracne or other acneform disease consistent with chloracne
• Type 2 diabetes (also known as Type II diabetes mellitus or adult-onset diabetes)
• Hodgkin’s disease
• Ischemic heart disease (including, but not limited to, acute, subacute, and old myocardial infarction; atherosclerotic cardiovascular disease including coronary artery disease (including coronary spasm) and coronary bypass surgery; and stable, unstable and Prinzmetal’s angina)NOTE : For purposes of this section, the term ischemic heart disease does not include hypertension or peripheral manifestations of arteriosclerosis such as peripheral vascular disease or stroke, or any other condition that does not qualify within the generally accepted medical definition of Ischemic heart disease.
• All chronic B-cell leukemias (including, but not limited to, hairy-cell leukemia and chronic lymphocytic leukemia)
• Multiple myeloma
• Non-Hodgkin’s lymphoma
• Parkinson’s disease
• Acute and subacute peripheral neuropathy –NOTE : For purposes of this section, the term acute and subacute peripheral neuropathy means transient peripheral neuropathy that appears within weeks or months of exposure to an herbicide agent and resolves within two years of the date of onset. This is a very difficult requirement for any veteran to meet.
• Porphyria cutanea tarda
• Prostate cancer
• Respiratory cancers (cancer of the lung, bronchus, larynx, or trachea)
• Soft-tissue sarcoma (other than osteosarcoma, chondrosarcoma, Kaposi’s sarcoma, or mesothelioma)NOTE : The term “soft-tissue sarcoma” includes the following:Adult fibrosarcoma
  • • Dermatofibrosarcoma protuberans
    • Malignant fibrous histiocytoma
    • Liposarcoma
    • Leiomyosarcoma
    • Epithelioid leiomyosarcoma (malignant leiomyoblastoma)
    • Rhabdomyosarcoma
    • Ectomesenchymoma
    • Angiosarcoma (hemangiosarcoma and lymphangiosarcoma)
    • Proliferating (systemic) angioendotheliomatosis
    • Malignant glomus tumor
    • Malignant hemangiopericytoma
    • Synovial sarcoma (malignant synovioma)
    • Malignant giant cell tumor of tendon sheath
    • Malignant schwannoma, including malignant schwannoma with rhabdomyoblastic differentiation (malignant Triton tumor), glandular and epithelioid malignant schwannomas
    • Malignant mesenchymoma
    • Malignant granular cell tumor
    • Alveolar soft part sarcoma
    • Epithelioid sarcoma
    • Clear cell sarcoma of tendons and aponeuroses
    • Extraskeletal Ewing’s sarcoma
    • Congenital and infantile fibrosarcoma
    • Malignant ganglioneuroma